Pharmaceutical Chemistry 1

Daten

Offizielle Daten in der Fachveröffentlichung für das folgende akademische Jahr: 2024-2025

Thematik

Introduction to the quality control of substances used in pharmaceutical compounding. Pharmacopoeal analysis of selected inorganic substances. Introduction to the pharmacokinetics and pharmacodynamics of drug action. Molecular aspects and structure activity relationship of selected groups of active pharmaceutical ingredients with central nervous system activity.

Vorlesungen

• 1.

  Introduction. History and development of drug control. The European Pharmacopoeia. The pharmacopoeial nomenclature of substances.

  - Almási Attila
• 2.

  Introduction. History and development of drug control. The European Pharmacopoeia. The pharmacopoeial nomenclature of substances.

  - Almási Attila
• 3.

  Physical and physicochemical methods of the European Pharmacopoeia.

  Identification and qualitative tests of the European Pharmacopoeia.

  - Kulcsár Győző Kornél
• 4.

  Physical and physicochemical methods of the European Pharmacopoeia.

  Identification and qualitative tests of the European Pharmacopoeia.

  - Kulcsár Győző Kornél
• 5.

  Protein-specific test methods of the European Pharmacopoeia.

  - Almási Attila
• 6.

  Protein-specific test methods of the European Pharmacopoeia.

  - Almási Attila
• 7.

  The fate of xenobiotics in the body.

  The receptor theory.

  - Rozmer Zsuzsanna
• 8.

  The fate of xenobiotics in the body.

  The receptor theory.

  - Rozmer Zsuzsanna
• 9.

  Molecular basis of drug action. Physico-chemical parameters affecting drug-target interactions.

  - Rozmer Zsuzsanna
• 10.

  Molecular basis of drug action. Physico-chemical parameters affecting drug-target interactions.

  - Rozmer Zsuzsanna
• 11.

  Structural and physical chemical basis of drug action. Structure-activity relationships. The stereochemistry of the molecules.

  - Kulcsár Győző Kornél
• 12.

  Structural and physical chemical basis of drug action. Structure-activity relationships. The stereochemistry of the molecules.

  - Kulcsár Győző Kornél
• 13.

  Transport processes. Transporters and ion channels as drug targets.

  - Fülöpné Kiss Edit
• 14.

  Transport processes. Transporters and ion channels as drug targets.

  - Fülöpné Kiss Edit
• 15.

  Central and peripheral receptors. Receptors as drug targets.

  - Fülöpné Kiss Edit
• 16.

  Central and peripheral receptors. Receptors as drug targets.

  - Fülöpné Kiss Edit
• 17.

  Structure and functions of enzymes. Enzymes as drug targets.

  - Fülöpné Kiss Edit
• 18.

  Structure and functions of enzymes. Enzymes as drug targets.

  - Fülöpné Kiss Edit
• 19.

  Phase 1 metabolic transformations.

  - Almási Attila
• 20.

  Phase 1 metabolic transformations.

  - Almási Attila
• 21. Phase 2 metabolic transformations. - Almási Attila
• 22. Phase 2 metabolic transformations. - Almási Attila
• 23.

  General anesthetics.

  - Rozmer Zsuzsanna
• 24.

  General anesthetics.

  - Rozmer Zsuzsanna
• 25.

  Narcotic analgesics.

  - Kovács-Rozmer Katalin
• 26.

  Narcotic analgesics.

  - Kovács-Rozmer Katalin
• 27.

  Nootropic agents and analeptics.

  - Kovács-Rozmer Katalin
• 28.

  Nootropic agents and analeptics.

  - Kovács-Rozmer Katalin

Praktika

• 1. Laboratory safety and accident protection. The pharmacopoeial nomenclature of substances. Identification and qualitative tests of the European Pharmacopoeia. Limit tests. Acidum hydrochloridum dilutum.
• ...

  2. Laboratory safety and accident protection. The pharmacopoeial nomenclature of substances. Identification and qualitative tests of the European Pharmacopoeia. Limit tests. Acidum hydrochloridum dilutum.

  3. Laboratory safety and accident protection. The pharmacopoeial nomenclature of substances. Identification and qualitative tests of the European Pharmacopoeia. Limit tests. Acidum hydrochloridum dilutum.
• 4. Laboratory safety and accident protection. The pharmacopoeial nomenclature of substances. Identification and qualitative tests of the European Pharmacopoeia. Limit tests. Acidum hydrochloridum dilutum.
• 5. Calculation of results. Experimental errors. Natrii chloridum, Chloraminum.
• 6. Calculation of results. Experimental errors. Natrii chloridum, Chloraminum.
• 7. Calculation of results. Experimental errors. Natrii chloridum, Chloraminum.
• 8. Calculation of results. Experimental errors. Natrii chloridum, Chloraminum.
• 9. Inorganic pharmacopoeial substances I. Halogens Natrii bromidum., Kalii bromidum, Ammonii bromidum, Kalii chloridum.
• ...

  10. Inorganic pharmacopoeial substances I. Halogens Natrii bromidum., Kalii bromidum, Ammonii bromidum, Kalii chloridum.

  11. Inorganic pharmacopoeial substances I. Halogens Natrii bromidum., Kalii bromidum, Ammonii bromidum, Kalii chloridum.
• 12. Inorganic pharmacopoeial substances I. Halogens Natrii bromidum., Kalii bromidum, Ammonii bromidum, Kalii chloridum.
• 13. Inorganic pharmacopoeial substances II. Oxygen group. Aqua purificata, Hydrogenii peroxidum 30 per centum, Natrii hydroxidum.
• ...

  14. Inorganic pharmacopoeial substances II. Oxygen group. Aqua purificata, Hydrogenii peroxidum 30 per centum, Natrii hydroxidum.

  15. Inorganic pharmacopoeial substances II. Oxygen group. Aqua purificata, Hydrogenii peroxidum 30 per centum, Natrii hydroxidum.
• 16. Inorganic pharmacopoeial substances II. Oxygen group. Aqua purificata, Hydrogenii peroxidum 30 per centum, Natrii hydroxidum.
• 17. Inorganic pharmacopoeial substances III. Sulphur compounds. Natrii thiosulfas, Natrii metabisulfis, Natrii sulfas, Sulphur ad usum externum.
• ...

  18. Inorganic pharmacopoeial substances III. Sulphur compounds. Natrii thiosulfas, Natrii metabisulfis, Natrii sulfas, Sulphur ad usum externum.

  19. Inorganic pharmacopoeial substances III. Sulphur compounds. Natrii thiosulfas, Natrii metabisulfis, Natrii sulfas, Sulphur ad usum externum.
• 20. Inorganic pharmacopoeial substances III. Sulphur compounds. Natrii thiosulfas, Natrii metabisulfis, Natrii sulfas, Sulphur ad usum externum.
• 21. Inorganic pharmacopoeial substances IV. Nitrogen compounds. Ammonii chloridum, Natrii nitris, Kalii nitras, Bismuthi subnitras.
• ...

  22. Inorganic pharmacopoeial substances IV. Nitrogen compounds. Ammonii chloridum, Natrii nitris, Kalii nitras, Bismuthi subnitras.

  23. Inorganic pharmacopoeial substances IV. Nitrogen compounds. Ammonii chloridum, Natrii nitris, Kalii nitras, Bismuthi subnitras.
• 24. Inorganic pharmacopoeial substances IV. Nitrogen compounds. Ammonii chloridum, Natrii nitris, Kalii nitras, Bismuthi subnitras.
• 25. 1st Midterm Test. Inorganic pharmacopoeial substances V. Phosphorous compounds. Calcii hydrogenophosphas, Tricalcii phosphas, Natrii dihydrogenophosphas, Dinatrii phosphas.
• ...

  26. 1st Midterm Test. Inorganic pharmacopoeial substances V. Phosphorous compounds. Calcii hydrogenophosphas, Tricalcii phosphas, Natrii dihydrogenophosphas, Dinatrii phosphas.

  27. 1st Midterm Test. Inorganic pharmacopoeial substances V. Phosphorous compounds. Calcii hydrogenophosphas, Tricalcii phosphas, Natrii dihydrogenophosphas, Dinatrii phosphas.
• 28. 1st Midterm Test. Inorganic pharmacopoeial substances V. Phosphorous compounds. Calcii hydrogenophosphas, Tricalcii phosphas, Natrii dihydrogenophosphas, Dinatrii phosphas.
• 29. Inorganic pharmacopoeial substances VI. Carbon compounds. Carbo activatus, Calcii carbonas, Natrii carbonas, Natrii hydrogencarbonas.
• ...

  30. Inorganic pharmacopoeial substances VI. Carbon compounds. Carbo activatus, Calcii carbonas, Natrii carbonas, Natrii hydrogencarbonas.

  31. Inorganic pharmacopoeial substances VI. Carbon compounds. Carbo activatus, Calcii carbonas, Natrii carbonas, Natrii hydrogencarbonas.
• 32. Inorganic pharmacopoeial substances VI. Carbon compounds. Carbo activatus, Calcii carbonas, Natrii carbonas, Natrii hydrogencarbonas.
• 33. Inorganic pharmacopoeial substances VII. Pharmaceutical excipients (Seminars).
• ...

  34. Inorganic pharmacopoeial substances VII. Pharmaceutical excipients (Seminars).

  35. Inorganic pharmacopoeial substances VII. Pharmaceutical excipients (Seminars).
• 36. Inorganic pharmacopoeial substances VII. Pharmaceutical excipients (Seminars).
• 37. Inorganic pharmacopoeial substances VIII. Alkaline earth metals. Earth metals. Silicon compounds. Magnesii sulfas, Magnesii subcarbonas, Magnesii oxydum, Magnesii trisilicas, Silica, colloidal hydrated, Acidum boricum, Borax.
• ...

  38. Inorganic pharmacopoeial substances VIII. Alkaline earth metals. Earth metals. Silicon compounds. Magnesii sulfas, Magnesii subcarbonas, Magnesii oxydum, Magnesii trisilicas, Silica, colloidal hydrated, Acidum boricum, Borax.

  39. Inorganic pharmacopoeial substances VIII. Alkaline earth metals. Earth metals. Silicon compounds. Magnesii sulfas, Magnesii subcarbonas, Magnesii oxydum, Magnesii trisilicas, Silica, colloidal hydrated, Acidum boricum, Borax.
• 40. Inorganic pharmacopoeial substances VIII. Alkaline earth metals. Earth metals. Silicon compounds. Magnesii sulfas, Magnesii subcarbonas, Magnesii oxydum, Magnesii trisilicas, Silica, colloidal hydrated, Acidum boricum, Borax.
• 41. Inorganic pharmacopoeial substances IX. Metals. Aluminii oxidum hydricum, Aluminii sulfas, Zinci oxydum, Zinci chloridum, Ferrosi sulfas, Kalii permanganas.
• ...

  42. Inorganic pharmacopoeial substances IX. Metals. Aluminii oxidum hydricum, Aluminii sulfas, Zinci oxydum, Zinci chloridum, Ferrosi sulfas, Kalii permanganas.

  43. Inorganic pharmacopoeial substances IX. Metals. Aluminii oxidum hydricum, Aluminii sulfas, Zinci oxydum, Zinci chloridum, Ferrosi sulfas, Kalii permanganas.
• 44. Inorganic pharmacopoeial substances IX. Metals. Aluminii oxidum hydricum, Aluminii sulfas, Zinci oxydum, Zinci chloridum, Ferrosi sulfas, Kalii permanganas.
• 45. Physico-chemical parameters influencing the biological effect (solubility, pKa, logP). Determination of logP.
• ...

  46. Physico-chemical parameters influencing the biological effect (solubility, pKa, logP). Determination of logP.

  47. Physico-chemical parameters influencing the biological effect (solubility, pKa, logP). Determination of logP.
• 48. Physico-chemical parameters influencing the biological effect (solubility, pKa, logP). Determination of logP.
• 49. Classification of functional groups and heterocycles (seminar).
• ...

  50. Classification of functional groups and heterocycles (seminar).

  51. Classification of functional groups and heterocycles (seminar).
• 52. Classification of functional groups and heterocycles (seminar).
• 53. Basics of stereochemistry. Stereochemistry of morphine and derivatives.
• ...

  54. Basics of stereochemistry. Stereochemistry of morphine and derivatives.

  55. Basics of stereochemistry. Stereochemistry of morphine and derivatives.
• 56. Basics of stereochemistry. Stereochemistry of morphine and derivatives.

Seminare

Materialien zum Aneignen des Lehrstoffes

Obligatorische Literatur

D. A. Williams, T. L. Lemke (eds.): Foye's Principles of Medicinal Chemistry, 7th edition, Lippincott Williams & Wilkins, Philadelphia, 2013

Vom Institut veröffentlichter Lehrstoff

Attila Almási, Zsuzsanna Rozmer, Pál Perjési: Pharmaceutical Chemistry I. Laboratory Experiments and Commentary, electronic educational material, PTE 2014

Skript

Pharmaceutical Chemistry Practice I., Laboratory manual, University of Pécs, 2015

Empfohlene Literatur

European Pharmacopoeia, EDQM Publication.

Lecture notes.

Voraussetzung zum Absolvieren des Semesters

Acknowledgement of the course is in accord with the Code of Studies and Examinations. Participation is both the lectures and the practices is obligatory. Maximum three absences can be accepted both from lectures and practices. There is an obligation to write two midterm tests (week 7. and 12.) from the topics of theory and practice. Students must reach the minimum level of 60% at one test, but the average of the two tests should be above 50 %. Students can have one retake in the end of the semester, if both tests are failed. Students have to write at least four mini-tests on the practices. The average of the results must be at least 50%. The practical work (results of the written tests and the experimental work) is evaluated by a practical grade. Satisfactory (2) evaluation is the minimum requirement of acknowledgement of the semester.

Semesteranforderungen

If the student did not take part writing the midterm test, she or he can participate the retake, only. There is no chance for extra possibilities.

Möglichkeiten zur Nachholung der Fehlzeiten

There is no opportunity to make up missed classes.

Prüfungsfragen

Written exam covering the topics of the lectures and the laboratory practices. The result of the written exam must be above 60%. The final grade is based on results of the midterm tests and the written exam. Maximum contribution of the results of the midterm tests to the total score of the written exam is 25%.

Prüfer

• Almási Attila
• Kovács-Rozmer Katalin
• Perjési Pál
• Rozmer Zsuzsanna

Praktika, Seminarleiter/innen

• Almási Attila
• Kovács-Rozmer Katalin
• Mészáros Petra